|
 |
|
|
| |
|
|
|
|
| Table 2. Estimated proportions of adults and adolescents with HIV/AIDS for whom a CD4 test was performed within 12
months after HIV diagnosis, by year of diagnosis and selected characteristics, 2001–2003—33 states with
confidential name-based HIV infection reporting |
|
|
|
|
View PDF
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
2001 |
|
2002 |
|
2003 |
| CD4 counta |
No CD4 count |
Total |
|
CD4 counta |
No CD4 count |
Total |
|
CD4 counta |
No CD4 count |
Total |
| |
No. |
(%) |
No. |
(%) |
No. |
|
No. |
(%) |
No. |
(%) |
No. |
|
No. |
(%) |
No. |
(%) |
No. |
| Sex |
| Male |
15,734 |
(55.1) |
12,821 |
(44.9) |
28,555 |
|
15,895 |
(57.6) |
11,722 |
(42.4) |
27,617 |
|
16,083 |
(59.1) |
11,117 |
(40.9) |
27,200 |
| Female |
6,086 |
(49.7) |
6,162 |
(50.3) |
12,248 |
|
5,747 |
(51.0) |
5,516 |
(49.0) |
11,263 |
|
5,849 |
(54.8) |
4,831 |
(45.2) |
10,680 |
| Age as of end of year (yrs) |
| 13–14 |
26 |
(48.4) |
28 |
(51.6) |
53 |
|
23 |
(50.2) |
23 |
(49.8) |
46 |
|
33 |
(61.7) |
20 |
(38.3) |
53 |
| 15–24 |
1,812 |
(42.7) |
2,434 |
(57.3) |
4,247 |
|
1,717 |
(41.2) |
2,450 |
(58.8) |
4,167 |
|
1,942 |
(44.5) |
2,422 |
(55.5) |
4,364 |
| 25–34 |
5,891 |
(51.9) |
5,457 |
(48.1) |
11,348 |
|
5,673 |
(52.6) |
5,104 |
(47.4) |
10,778 |
|
5,509 |
(55.3) |
4,447 |
(44.7) |
9,956 |
| 35–44 |
8,141 |
(54.5) |
6,787 |
(45.5) |
14,927 |
|
8,210 |
(58.3) |
5,861 |
(41.7) |
14,071 |
|
8,232 |
(60.7) |
5,329 |
(39.3) |
13,561 |
| 45–54 |
4,272 |
(57.6) |
3,150 |
(42.4) |
7,422 |
|
4,348 |
(61.2) |
2,760 |
(38.8) |
7,108 |
|
4,471 |
(61.9) |
2,748 |
(38.1) |
7,219 |
| 55–64 |
1,289 |
(60.4) |
846 |
(39.6) |
2,135 |
|
1,303 |
(62.5) |
782 |
(37.5) |
2,085 |
|
1,325 |
(62.9) |
782 |
(37.1) |
2,107 |
| ≥65 |
390 |
(58.2) |
281 |
(41.8) |
671 |
|
369 |
(58.9) |
257 |
(41.1) |
626 |
|
421 |
(67.8) |
200 |
(32.2) |
620 |
| Transmission category |
| Male adult or adolescent |
| Male-to-male sexual contact |
9,170 |
(55.3) |
7,419 |
(44.7) |
16,589 |
|
9,565 |
(56.9) |
7,247 |
(43.1) |
16,812 |
|
9,806 |
(58.5) |
6,957 |
(41.5) |
16,764 |
| Injection drug use |
2,865 |
(55.5) |
2,298 |
(44.5) |
5,162 |
|
2,689 |
(61.5) |
1,680 |
(38.5) |
4,370 |
|
2,577 |
(61.8) |
1,592 |
(38.2) |
4,169 |
| Male-to-male sexual contact and injection drug use |
916 |
(60.2) |
606 |
(39.8) |
1,522 |
|
921 |
(64.6) |
506 |
(35.4) |
1,427 |
|
888 |
(63.6) |
508 |
(36.4) |
1,396 |
| Heterosexual contactb |
2,662 |
(52.4) |
2,419 |
(47.6) |
5,081 |
|
2,600 |
(53.8) |
2,230 |
(46.2) |
4,829 |
|
2,695 |
(57.3) |
2,007 |
(42.7) |
4,702 |
| Otherc |
121 |
(60.3) |
80 |
(39.7) |
200 |
|
120 |
(67.0) |
59 |
(33.0) |
179 |
|
117 |
(68.6) |
53 |
(31.4) |
170 |
| Female adult or adolescent |
| Injection drug use |
1,440 |
(50.2) |
1,429 |
(49.8) |
2,869 |
|
1,290 |
(53.7) |
1,113 |
(46.3) |
2,403 |
|
1,277 |
(56.8) |
972 |
(43.2) |
2,250 |
| Heterosexual contactb |
4,527 |
(49.3) |
4,646 |
(50.7) |
9,173 |
|
4,347 |
(50.1) |
4,331 |
(49.9) |
8,678 |
|
4,450 |
(54.0) |
3,786 |
(46.0) |
8,236 |
| Otherc |
119 |
(57.7) |
87 |
(42.3) |
207 |
|
110 |
(60.8) |
71 |
(39.2) |
181 |
|
121 |
(62.4) |
73 |
(37.6) |
195 |
| Race/ethnicity |
| White, not Hispanic |
6,695 |
(59.9) |
4,481 |
(40.1) |
11,176 |
|
6,939 |
(61.4) |
4,355 |
(38.6) |
11,294 |
|
7,042 |
(63.8) |
3,999 |
(36.2) |
11,041 |
| Black, not Hispanic |
10,937 |
(51.4) |
10,331 |
(48.6) |
21,268 |
|
10,514 |
(52.6) |
9,462 |
(47.4) |
19,976 |
|
10,665 |
(55.8) |
8,450 |
(44.2) |
19,115 |
| Hispanic |
3,812 |
(50.0) |
3,809 |
(50.0) |
7,621 |
|
3,791 |
(55.0) |
3,106 |
(45.0) |
6,897 |
|
3,802 |
(54.1) |
3,226 |
(45.9) |
7,029 |
| Asian/Pacific Islander |
142 |
(53.8) |
122 |
(46.2) |
265 |
|
162 |
(52.1) |
149 |
(47.9) |
311 |
|
223 |
(61.4) |
140 |
(38.6) |
363 |
| American Indian/Alaska Native |
114 |
(66.8) |
57 |
(33.2) |
171 |
|
127 |
(63.6) |
72 |
(36.4) |
199 |
|
109 |
(58.3) |
78 |
(41.7) |
187 |
| Unknown |
120 |
(39.5) |
184 |
(60.5) |
303 |
|
109 |
(53.7) |
94 |
(46.3) |
202 |
|
91 |
(62.2) |
55 |
(37.8) |
146 |
| Totald |
21,820 |
(53.5) |
18,983 |
(46.5) |
40,804 |
|
21,642 |
(55.7) |
17,238 |
(44.3) |
38,880 |
|
21,932 |
(57.9) |
15,949 |
(42.1) |
37,880 |
|
| Note. These numbers do not represent actual cases in persons with a diagnosis of HIV infection or AIDS. Rather, these numbers are point estimates of case counts that have been adjusted for
reporting delays and for redistribution of cases in persons initially reported without an identified risk factor. The estimates have not been adjusted for incomplete reporting. |
| Since 2000, the following states have had laws or regulations requiring confidential name-based HIV infection reporting: Alabama, Alaska, Arizona, Arkansas, Colorado, Florida, Idaho, Indiana, Iowa,
Kansas, Louisiana, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South
Dakota, Tennessee, Texas, Utah, Virginia, West Virginia, Wisconsin, and Wyoming. Since July 1997, Florida has had confidential name-based HIV infection reporting for new diagnoses only. |
|
|
|
| a |
When only CD4 percentage was available, a CD4 count was interpreted. |
| b |
With person at high risk or with a diagnosis of HIV infection or AIDS. |
| c |
Includes hemophilia, blood transfusion, perinatal exposure, and risk factor not reported or identified. |
| d |
Because column totals were calculated independently of the values for the subpopulations, the values in each column may not sum to the column total. |
|
|
|
|
|
|
|
